AU6546898A - Secreted proteins and polynucleotides encoding them - Google Patents

Secreted proteins and polynucleotides encoding them

Info

Publication number
AU6546898A
AU6546898A AU65468/98A AU6546898A AU6546898A AU 6546898 A AU6546898 A AU 6546898A AU 65468/98 A AU65468/98 A AU 65468/98A AU 6546898 A AU6546898 A AU 6546898A AU 6546898 A AU6546898 A AU 6546898A
Authority
AU
Australia
Prior art keywords
polynucleotides encoding
secreted proteins
secreted
proteins
polynucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65468/98A
Inventor
Michael J. Agostino
Kenneth Jacobs
Edward R. Lavallie
John M Mccoy
David Merberg
Lisa A. Racie
Vikki Spaulding
Maurice Treacy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Publication of AU6546898A publication Critical patent/AU6546898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
AU65468/98A 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them Abandoned AU6546898A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US81538197A 1997-03-11 1997-03-11
US08815381 1997-03-11
US3632198A 1998-03-06 1998-03-06
US09036321 1998-03-06
PCT/US1998/004601 WO1998040404A2 (en) 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them

Publications (1)

Publication Number Publication Date
AU6546898A true AU6546898A (en) 1998-09-29

Family

ID=26713058

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65468/98A Abandoned AU6546898A (en) 1997-03-11 1998-03-09 Secreted proteins and polynucleotides encoding them

Country Status (5)

Country Link
EP (1) EP0970109A2 (en)
JP (1) JP2001514520A (en)
AU (1) AU6546898A (en)
CA (1) CA2283193A1 (en)
WO (1) WO1998040404A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1144603A3 (en) * 1999-01-22 2002-02-06 Memorec Medical Molecular Research Cologne Stoffel GmbH Protease
EP1683867B1 (en) 1999-06-18 2014-04-09 Research Foundation Of State University Of New York Groups of Borrelia burgdorferi and Borrelia afzelii that cause lyme disease in humans
CA2402310A1 (en) 2000-03-08 2001-09-13 Complexe Hospitalier De La Sagamie Very low density lipoprotein receptor polymorphisms and uses therefor
US20020132244A1 (en) 2000-09-27 2002-09-19 Xiao-Cheng Li-Sucholeiki Methods for detecting rare polymorphic variants in genomic DNA sequences
US9072766B2 (en) 2010-11-18 2015-07-07 Beth Israel Deaconess Medical Center, Inc. Methods of treating obesity by inhibiting nicotinamide N-methyl transferase (NNMT)
KR20210082212A (en) * 2018-10-25 2021-07-02 아지노모토 가부시키가이샤 secretory production method of protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby

Also Published As

Publication number Publication date
WO1998040404A3 (en) 1998-12-30
WO1998040404A2 (en) 1998-09-17
CA2283193A1 (en) 1998-09-17
JP2001514520A (en) 2001-09-11
EP0970109A2 (en) 2000-01-12

Similar Documents

Publication Publication Date Title
AU3381797A (en) Secreted proteins and polynucleotides encoding them
AU6050898A (en) Secreted proteins and polynucleotides encoding them
AU6578398A (en) Secreted proteins and polynucleotides encoding them
AU6777298A (en) Secreted proteins and polynucleotides encoding them
AU3890797A (en) Secreted proteins and polynucleotides encoding them
AU7159898A (en) Secreted proteins and polynucleotides encoding them
AU7807298A (en) Secreted proteins and polynucleotides encoding them
AU6702298A (en) Secreted proteins and polynucleotides encoding them
AU1101199A (en) Secreted proteins and polynucleotides encoding them
AU3810097A (en) Secreted proteins and polynucleotides encoding them
AU1417899A (en) Secreted proteins and polynucleotides encoding them
AU7142498A (en) Secreted proteins and polynucleotides encoding them
AU5828398A (en) Secreted proteins and polynucleotides encoding them
AU6337398A (en) Secreted proteins and polynucleotides encoding them
AU6590898A (en) Secreted proteins and polynucleotides encoding them
AU2459397A (en) Secreted proteins and polynucleotides encoding them
AU8824098A (en) Secreted proteins and polynucleotides encoding them
AU6546898A (en) Secreted proteins and polynucleotides encoding them
AU5801998A (en) Secreted proteins and polynucleotides encoding them
AU7826498A (en) Secreted proteins and polynucleotides encoding them
AU2728697A (en) Secreted proteins and polynucleotides encoding them
AU1536399A (en) Secreted proteins and polynucleotides encoding them
AU6765098A (en) Secreted proteins and polynucleotides encoding them
AU6439598A (en) Secreted proteins and polynucleotides encoding them
AU5958698A (en) Secreted proteins and polynucleotides encoding them